Rankings
▼
Calendar
FOLD Q1 2016 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$43M
Net Income
-$44M
EPS (Diluted)
$-0.35
Cash Flow
Operating Cash Flow
-$45M
Free Cash Flow
-$48M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$863M
Total Liabilities
$551M
Stockholders' Equity
$312M
Cash & Equivalents
$24M
← FY 2016
All Quarters
Q2 2016 →